Results of a multicenter pilot study of weekly nab-paclitaxel, carboplatin with bevacizumab, and trastuzumab as neoadjuvant therapy in HER2+locally advanced breast cancer with SPARC correlatives Meeting Abstract

cited authors

  • Yardley, D. A., Raefsky, E., Castillo, R., Lahiry, A., LoCicero, R., Thompson, D., Shastry, M., Trieu, V., Knauer, D., Desai, N.

authors

Publication Date

  • May 20, 2009

webpage

published in

category

volume

  • 27

issue

  • 15

WoS Citations

  • 2

WoS References

  • 0